Advancing precision medicine in esophageal squamous cell carcinoma using patient-derived organoids
Abstract Background Patient-derived organoids (PDOs) represent a promising approach for replicating the characteristics of original tumors and facilitating drug testing for personalized treatments across diverse cancer types. However, clinical evidence regarding their application to esophageal cance...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2024-12-01
|
| Edice: | Journal of Translational Medicine |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s12967-024-05967-1 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
